This week, researchers from the Institute of Nano Science and Technology announced the development of a new generation of bioengineered micronanorobots that can self-adapt to treat gastrointestinal inflammation. The robots, which measure just 0.1 millimeters long, have been engineered to detect inflammatory signals and deliver targeted doses of drugs to affected areas of the gastrointestinal tract. This breakthrough could revolutionize the way we treat gastrointestinal inflammation, reducing the need for invasive procedures and providing patients with a more efficient, personalized treatment.

Read Full Article Here

source: Phys.org